Blood Preparation Market to touch $78.5 Bn by 2025| Prominent Players: Bayer, Aralez Pharmaceuticals, Pfizer, GlaxoSmithKline, AstraZeneca

Global Blood Preparation Market is set to exceed USD 78.5 billion by 2025; according to a new research report by Global Market Insights. Growing geriatric population base prone to suffer from conditions such as liver cirrhosis will act as driving factor for blood preparation market. Explosive outbreaks such as dengue fever result in high demand for blood components majorly platelets and platelet products should drive business growth. Furthermore growing awareness about blood donation and numerous initiatives undertaken by government to escalate number of blood donations should positively impact industry growth.

Surge in number of surgeries will stimulate demand for whole blood thereby fueling industry growth. Strong product pipeline of anti-coagulants along with technological advancements should propel blood preparation market growth over the forecast period. However, risk of infection post blood transfusion will hamper industry growth to certain limit over the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/790

On the product front, the blood preparation industry is segmented into blood derivatives, components and whole blood. Blood components refer to products derived from platelet-rich plasma. This segment is likely to account for a considerable share in the coming years, owing to the increasing use of frozen plasma, platelet concentrate, leucocyte reduced RBCs, packed red cells and whole blood components. The whole blood product segment of the blood preparation market generated the highest revenue share, having accounted over 48% in 2015. Blood derivatives segment stood second by contributing 34% of the overall blood preparation industry share in 2015.

Anti-coagulants includes heparins, vitamin K antagonists, direct thrombin inhibitors, and direct factor Xa inhibitors. Heparin dominated anti-coagulants segment by accounting more than 30% market share in 2018. High adoption of heparin injection to reduce clotting ability of blood along with its high application during bypass surgery, kidney dialysis, open-heart surgery and blood transfusions to prevent formation of blood clots should drive heparin anticoagulant market.

Pulmonary embolism application market accounted for USD 12.4 billion in 2018. Pulmonary embolism is frequent complication faced by hospitalized patients, making it one of the primary causes of preventable deaths. Anticoagulation is presently considered to be the central component for treating acute pulmonary embolism should drive pulmonary embolism anticoagulants market growth over the projection period. Unfractionated heparin or low-molecular-weight heparin along with oral vitamin K antagonists have been conventional treatment therapies for pulmonary embolism.

With reference to antithrombotic and anticoagulants type of drugs pipeline, blood preparation market is segmented into fibrinolytic, anticoagulants and platelet aggregation inhibitors. Rise in the incidences of thrombosis, and growing geriatric population has raised the demand for more efficacious drugs. Due to these reasons, anticoagulants led the overall blood preparation industry by collecting revenue over USD 17 billion in 2015. Government initiative regarding the awareness and prevention of thrombosis disorders is also likely to give a major push to the industry growth.

Developed and well equipped healthcare infrastructure in U.S. will propel the regional blood preparation market. U.S. also witnesses an increasing prevalence of thrombocytosis disorder which will contribute toward industry growth. U.S. market is estimated to surpass 25 billion by 2024, backed by several government initiative and high patient awareness levels.

The major industry participants are focusing on the research for efficient and cost-effective drugs to cure blood related disorders. To cope up with the ever-rising patient pool, the blood preparation market players are constantly engaged in developing innovative technologies. The companies are set to introduce rapid and easy handling instruments for the preparation of blood components. Key industry players include Pfizer, Sanofi Aventis, Leo Pharma, Bristol-Myers, Shandong East Chemical, GlaxoSmithKline, Celgene, Baxter Healthcare, and AstraZeneca.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/790

Blood Preparation Market, by Product (USD Million)

Blood and blood components:
Whole blood
Blood components
Red blood cells
Platelets
Plasma
White blood cells

Anti-thrombotic and anticoagulants:
Platelet aggregation inhibitors
Glycoprotein inhibitors
COX inhibitors
ADP antagonists
Phosphodiesterase inhibitors

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.